Paper
0
Humoral and cellular immune responses after 6 months of a heterologous SARS-CoV-2 booster with the protein-based PHH-1V vaccine in a phase IIb trial
Authors
Júlia Corominas,Carme Garriga
Antoni Prenafeta,Alexandra Moros,Manuel Cañete,Antonio Barreiro,Luis González‐González,Laia Madrenas,Irina Güell,Bonaventura Clotet,Nuria Izquierdo‐Useros,Dàlia Raϊch‐Regué,Marçal Gallemí,Julià Blanco,Edwards Pradenas,Benjamin Trinité,Julia Prado,Raúl Pérez‐Caballero,Laia Bernad,Montserrat Plana,Ignasi Esteban,Elena Aurrecoechea,Rachel Taleb,Paula McSkimming,Álex Soriano,Jocelyn Nava,Jesse Anagua,Rafel Ramos,Ruth Martí‐Lluch,Aida Comes,Susana Otero‐Romero,Xavier Martínez‐Gómez,Lina Camacho-Arteaga,José Moltó,Susana Benet,Lucía Bailón,José Arribas,Alberto Borobia,Javier Parada,Jorge Navarro-Pérez,María Giner,Rafaël Lucas,María Jiménez,María Fernández,Melchor Álvarez‐Mon,Daniel Troncoso,Eunate Arana‐Arri,Susana Meijide,Natale Imaz-Ayo,Patricia García,Sofía Villa,Sara Fernández,Teresa Prat,Èlia Torroella,Laura Ferrer,Nuria Izquierdo-Useros,J Coll,José Gatell,Eunate Arana-Arri
+57 authors
,Sara Rodríguez-FernándezJournal
Published
Jan 13, 2025
Show more
Save
Tip0
TipSave
Abstract
Paper PDF
This PDF hasn't been uploaded yet.
Do not upload any copyrighted content to the site, only open-access content.
or